Pharmacokinetic Interaction Between Midazolam and ID-082 in Healthy Subjects
Status:
Completed
Trial end date:
2017-12-19
Target enrollment:
Participant gender:
Summary
A clinical study in healthy male subjects to investigate whether the administration of ID-082
can affect the fate in the body (amount and time of presence in the blood) of midazolam.